#METABOLOMICS WORKBENCH SIMR_Core_Facility_20230622_054105 DATATRACK_ID:4107 STUDY_ID:ST002755 ANALYSIS_ID:AN004472 PROJECT_ID:PR001716
VERSION             	1
CREATED_ON             	June 27, 2023, 2:52 pm
#PROJECT
PR:PROJECT_TITLE                 	Metabolomics Profiling of the Antiproliferative, Anti-migratory and
PR:PROJECT_TITLE                 	Anti-invasive Potential of Amlodipine in Lung Cancer Cells
PR:PROJECT_TYPE                  	LC-MS/MS
PR:PROJECT_SUMMARY               	Lung cancer is still among the most leading causes of cancer-related deaths
PR:PROJECT_SUMMARY               	across the world. Although chemotherapy is considered as a critical choice to
PR:PROJECT_SUMMARY               	manage/limit cancer growth in lung cancer patients with early-stage and advanced
PR:PROJECT_SUMMARY               	cancer stages, it has many limitations including, at least, the severe side
PR:PROJECT_SUMMARY               	effects and chemoresistance. The latter is one of the considerable challenges to
PR:PROJECT_SUMMARY               	lung cancer treatment. Therefore, identification of new alternative therapies
PR:PROJECT_SUMMARY               	with lesser cytotoxic effects when compared to the currently used
PR:PROJECT_SUMMARY               	chemotherapeutics is one of the current research approaches. Calcium channel
PR:PROJECT_SUMMARY               	blockers (CCBs) are emerging as anti-cancer agents in several cancer types. Our
PR:PROJECT_SUMMARY               	objective is to determine the cytotoxic effect of amlodipine on non-small cell
PR:PROJECT_SUMMARY               	lung cancer (NSCLC) cells. Colorimetric MTT cell proliferation assay was used to
PR:PROJECT_SUMMARY               	analyze cell viability following treatments with amlodipine in A549 and H1299
PR:PROJECT_SUMMARY               	NSCLC cell lines. ANOVA and Tukey’s multiple comparison test were used to
PR:PROJECT_SUMMARY               	detect statistical significance. Half maximal (50%) inhibitory concentration
PR:PROJECT_SUMMARY               	(IC50) values were obtained by applying nonlinear regression curve fit analysis.
PR:PROJECT_SUMMARY               	To assess the effect of amlodipine on A549 and H1299 NSCLC cells migration and
PR:PROJECT_SUMMARY               	invasion scratch wound-healing assay and cell invasion assay were used. Our
PR:PROJECT_SUMMARY               	study revealed that amlodipine significantly reduced proliferation of cancer
PR:PROJECT_SUMMARY               	cells in a dose-dependent fashion with half maximal (50%) inhibitory
PR:PROJECT_SUMMARY               	concentration (IC50) values of 23 and 25.66 µM in A549 and H1299 cells,
PR:PROJECT_SUMMARY               	respectively. Furthermore, amlodipine was able to reduce the invasiveness and
PR:PROJECT_SUMMARY               	migration of cancer cells, both of which are hallmarks in the pathogenesis of
PR:PROJECT_SUMMARY               	cancer, in both cell lines in a dose-dependent manner. Accordingly, our study
PR:PROJECT_SUMMARY               	provides empirical evidence that amlodipine expresses anti-cancer effect to
PR:PROJECT_SUMMARY               	NSCLC cells. However, additional investigations are required to further confirm
PR:PROJECT_SUMMARY               	our results on a larger scale at the clinical level.
PR:INSTITUTE                     	Sharjah Institute for Medical Research
PR:LAST_NAME                     	Facility
PR:FIRST_NAME                    	Core
PR:ADDRESS                       	M32, SIMR, College of Pharmacy, Health Sciences, University of Sharjah
PR:EMAIL                         	tims-tof@sharjah.ac.ae
PR:PHONE                         	065057656
#STUDY
ST:STUDY_TITLE                   	Metabolomics Profiling of the Antiproliferative, Anti-migratory and
ST:STUDY_TITLE                   	Anti-invasive Potential of Amlodipine in Lung Cancer Cells
ST:STUDY_TYPE                    	LC/MS/MS
ST:STUDY_SUMMARY                 	Lung cancer is still among the most leading causes of cancer-related deaths
ST:STUDY_SUMMARY                 	across the world. Although chemotherapy is considered as a critical choice to
ST:STUDY_SUMMARY                 	manage/limit cancer growth in lung cancer patients with early-stage and advanced
ST:STUDY_SUMMARY                 	cancer stages, it has many limitations including, at least, the severe side
ST:STUDY_SUMMARY                 	effects and chemoresistance. The latter is one of the considerable challenges to
ST:STUDY_SUMMARY                 	lung cancer treatment. Therefore, identification of new alternative therapies
ST:STUDY_SUMMARY                 	with lesser cytotoxic effects when compared to the currently used
ST:STUDY_SUMMARY                 	chemotherapeutics is one of the current research approaches. Calcium channel
ST:STUDY_SUMMARY                 	blockers (CCBs) are emerging as anti-cancer agents in several cancer types. Our
ST:STUDY_SUMMARY                 	objective is to determine the cytotoxic effect of amlodipine on non-small cell
ST:STUDY_SUMMARY                 	lung cancer (NSCLC) cells. Colorimetric MTT cell proliferation assay was used to
ST:STUDY_SUMMARY                 	analyze cell viability following treatments with amlodipine in A549 and H1299
ST:STUDY_SUMMARY                 	NSCLC cell lines. ANOVA and Tukey’s multiple comparison test were used to
ST:STUDY_SUMMARY                 	detect statistical significance. Half maximal (50%) inhibitory concentration
ST:STUDY_SUMMARY                 	(IC50) values were obtained by applying nonlinear regression curve fit analysis.
ST:STUDY_SUMMARY                 	To assess the effect of amlodipine on A549 and H1299 NSCLC cells migration and
ST:STUDY_SUMMARY                 	invasion scratch wound-healing assay and cell invasion assay were used. Our
ST:STUDY_SUMMARY                 	study revealed that amlodipine significantly reduced proliferation of cancer
ST:STUDY_SUMMARY                 	cells in a dose-dependent fashion with half maximal (50%) inhibitory
ST:STUDY_SUMMARY                 	concentration (IC50) values of 23 and 25.66 µM in A549 and H1299 cells,
ST:STUDY_SUMMARY                 	respectively. Furthermore, amlodipine was able to reduce the invasiveness and
ST:STUDY_SUMMARY                 	migration of cancer cells, both of which are hallmarks in the pathogenesis of
ST:STUDY_SUMMARY                 	cancer, in both cell lines in a dose-dependent manner. Accordingly, our study
ST:STUDY_SUMMARY                 	provides empirical evidence that amlodipine expresses anti-cancer effect to
ST:STUDY_SUMMARY                 	NSCLC cells. However, additional investigations are required to further confirm
ST:STUDY_SUMMARY                 	our results on a larger scale at the clinical level.
ST:INSTITUTE                     	Sharjah Institute for Medical Research
ST:LAST_NAME                     	Facility
ST:FIRST_NAME                    	Core
ST:ADDRESS                       	M32, SIMR, College of Pharmacy, Health Sciences, University of Sharjah
ST:EMAIL                         	tims-tof@sharjah.ac.ae
ST:PHONE                         	065057656
#SUBJECT
SU:SUBJECT_TYPE                  	Human
SU:SUBJECT_SPECIES               	Homo sapiens
SU:TAXONOMY_ID                   	9606
#SUBJECT_SAMPLE_FACTORS:         	SUBJECT(optional)[tab]SAMPLE[tab]FACTORS(NAME:VALUE pairs separated by |)[tab]Raw file names and additional sample data
SUBJECT_SAMPLE_FACTORS           	-	Amlodipine 01-01-10446	Treatment:Amlodipine	RAW_FILE_NAME=Amlodipine 01-01-10446.d
SUBJECT_SAMPLE_FACTORS           	-	Amlodipine 01-02-10447	Treatment:Amlodipine	RAW_FILE_NAME=Amlodipine 01-02-10447.d
SUBJECT_SAMPLE_FACTORS           	-	Amlodipine 02-01-10448	Treatment:Amlodipine	RAW_FILE_NAME=Amlodipine 02-01-10448.d
SUBJECT_SAMPLE_FACTORS           	-	Amlodipine 02-02-10449	Treatment:Amlodipine	RAW_FILE_NAME=Amlodipine 02-02-10449.d
SUBJECT_SAMPLE_FACTORS           	-	Amlodipine 03-01-10450	Treatment:Amlodipine	RAW_FILE_NAME=Amlodipine 03-01-10450.d
SUBJECT_SAMPLE_FACTORS           	-	Amlodipine 03-02-10451	Treatment:Amlodipine	RAW_FILE_NAME=Amlodipine 03-02-10451.d
SUBJECT_SAMPLE_FACTORS           	-	Amlodipine 04-01-10452	Treatment:Amlodipine	RAW_FILE_NAME=Amlodipine 04-01-10452.d
SUBJECT_SAMPLE_FACTORS           	-	Amlodipine 04-02-10453	Treatment:Amlodipine	RAW_FILE_NAME=Amlodipine 04-02-10453.d
SUBJECT_SAMPLE_FACTORS           	-	Amlodipine 05-01-10454	Treatment:Amlodipine	RAW_FILE_NAME=Amlodipine 05-01-10454.d
SUBJECT_SAMPLE_FACTORS           	-	Amlodipine 05-02-10455	Treatment:Amlodipine	RAW_FILE_NAME=Amlodipine 05-02-10455.d
SUBJECT_SAMPLE_FACTORS           	-	Amlodipine 06-01-10456	Treatment:Amlodipine	RAW_FILE_NAME=Amlodipine 06-01-10456.d
SUBJECT_SAMPLE_FACTORS           	-	Amlodipine 06-02-10457	Treatment:Amlodipine	RAW_FILE_NAME=Amlodipine 06-02-10457.d
SUBJECT_SAMPLE_FACTORS           	-	Control 01-01-10433	Treatment:Control	RAW_FILE_NAME=Control 01-01-10433.d
SUBJECT_SAMPLE_FACTORS           	-	Control 01-02-10434	Treatment:Control	RAW_FILE_NAME=Control 01-02-10434.d
SUBJECT_SAMPLE_FACTORS           	-	Control 02-01-10435	Treatment:Control	RAW_FILE_NAME=Control 02-01-10435.d
SUBJECT_SAMPLE_FACTORS           	-	Control 02-02-10436	Treatment:Control	RAW_FILE_NAME=Control 02-02-10436.d
SUBJECT_SAMPLE_FACTORS           	-	Control 03-01-10437	Treatment:Control	RAW_FILE_NAME=Control 03-01-10437.d
SUBJECT_SAMPLE_FACTORS           	-	Control 03-02-10438	Treatment:Control	RAW_FILE_NAME=Control 03-02-10438.d
SUBJECT_SAMPLE_FACTORS           	-	Control 04-01-10439	Treatment:Control	RAW_FILE_NAME=Control 04-01-10439.d
SUBJECT_SAMPLE_FACTORS           	-	Control 04-02-10440	Treatment:Control	RAW_FILE_NAME=Control 04-02-10440.d
SUBJECT_SAMPLE_FACTORS           	-	Control 05-01-10441	Treatment:Control	RAW_FILE_NAME=Control 05-01-10441.d
SUBJECT_SAMPLE_FACTORS           	-	Control 05-02-10442	Treatment:Control	RAW_FILE_NAME=Control 05-02-10442.d
SUBJECT_SAMPLE_FACTORS           	-	Control 06-01-10443	Treatment:Control	RAW_FILE_NAME=Control 06-01-10443.d
SUBJECT_SAMPLE_FACTORS           	-	Control 06-02-10444	Treatment:Control	RAW_FILE_NAME=Control 06-02-10444.d
#COLLECTION
CO:COLLECTION_SUMMARY            	A549 human lung adenocarcinoma cell line was obtained from American Type Culture
CO:COLLECTION_SUMMARY            	Collection (ATCC, Manassas, VA, USA). Cells were maintained in Roswell Park
CO:COLLECTION_SUMMARY            	Memorial Institute (RPMI-1640) media supplemented with 10% fetal bovine serum
CO:COLLECTION_SUMMARY            	(FBS), 100 U/mL penicillin, and 0.1 mg/mL streptomycin in a humidified
CO:COLLECTION_SUMMARY            	atmosphere with 5% CO2 at 37°C.
CO:SAMPLE_TYPE                   	Lung
#TREATMENT
TR:TREATMENT_SUMMARY             	Amlodipine was purchased from Tocris Bioscience (Bristol, UK). Amlodipine was
TR:TREATMENT_SUMMARY             	dissolved in dimethyl sulfoxide (DMSO) to produce stock concentrations of 10, 50
TR:TREATMENT_SUMMARY             	and 100 mM DMSO. Of note, to minimize the cytotoxic effects of DMSO, the final
TR:TREATMENT_SUMMARY             	concentration has never exceeded 0.1% in all treatment groups. Furthermore, the
TR:TREATMENT_SUMMARY             	cells ere treated in a quadruplicate manner with DMSO as a positive control.
#SAMPLEPREP
SP:SAMPLEPREP_SUMMARY            	we used chloroform/methanol extraction protocol to increase the coverage of the
SP:SAMPLEPREP_SUMMARY            	extracted metabolites. At first, the samples (cells and buffer) were transferred
SP:SAMPLEPREP_SUMMARY            	into Eppendorf tubes then centrifuged at 14000 rpm for 5 minutes. Afterward, the
SP:SAMPLEPREP_SUMMARY            	buffer was discarded, and the cells were preserved. To each sample, 400 µL of
SP:SAMPLEPREP_SUMMARY            	the mixture containing one protease inhibitor tablet and 10 mL of lysis buffer
SP:SAMPLEPREP_SUMMARY            	was added. Following rest for 10 minutes, samples were transferred to 10 mL
SP:SAMPLEPREP_SUMMARY            	tubes, vortexed for 2–4 minutes, and sonicated with a COPLEY probe-sonicator
SP:SAMPLEPREP_SUMMARY            	(QSONICA SONICATOR, USA) for 30 seconds while utilizing a 30% amplifier in an
SP:SAMPLEPREP_SUMMARY            	ice bath. The samples were then transferred to Eppendorf tubes and centrifuged
SP:SAMPLEPREP_SUMMARY            	for 5 minutes at 14000 rpm. The supernatant was then transferred to another
SP:SAMPLEPREP_SUMMARY            	Eppendorf, and 400 µL of methanol and 300 µL of chloroform were added.
SP:SAMPLEPREP_SUMMARY            	Following that, the samples were vortexed for 30 seconds and centrifuged for 5
SP:SAMPLEPREP_SUMMARY            	minutes at 14000 rpm. After that, two metabolite-containing layers are obtained,
SP:SAMPLEPREP_SUMMARY            	after transferring the upper layer of each sample to glass vials, 400 µl of
SP:SAMPLEPREP_SUMMARY            	methanol was added, followed by vertexing and centrifugation. The remaining
SP:SAMPLEPREP_SUMMARY            	supernatant was transferred to the same glass vials used before for the drying
SP:SAMPLEPREP_SUMMARY            	step, with the remaining protein pellets being air-dried for proteomics. A dried
SP:SAMPLEPREP_SUMMARY            	metabolomics sample was resuspended in 200 µL (0.1% formic acid in water) and
SP:SAMPLEPREP_SUMMARY            	injected into HPLC to be analysed by Q-TOF MS.
SP:EXTRACT_STORAGE               	-80℃
#CHROMATOGRAPHY
CH:CHROMATOGRAPHY_SUMMARY        	amples were chromatographically separated by inline reversed-phase
CH:CHROMATOGRAPHY_SUMMARY        	chromatography using the Elute HPG 1300 pumps and Elute Autosampler (Bruker,
CH:CHROMATOGRAPHY_SUMMARY        	Darmstadt, Germany) with solvent A 0.1% FA in HPLC grade water and solvent B
CH:CHROMATOGRAPHY_SUMMARY        	0.1% FA in ACN. A Hamilton Intensity Solo 2 C18 column (100 mm x 2.1 mm, 1.8µm
CH:CHROMATOGRAPHY_SUMMARY        	beads) was maintained at 35C. For metabolomics, 10 µL was injected twice for
CH:CHROMATOGRAPHY_SUMMARY        	each sample and eluted using a 30-minute gradient as follows: 1% ACN was held
CH:CHROMATOGRAPHY_SUMMARY        	for 2 minutes, ramping to 99% ACN over 15 minutes, held at 99% ACN for 3 minutes
CH:CHROMATOGRAPHY_SUMMARY        	before re-equilibrating to 1% ACN for 10 minutes. Flow rates were 250 µL/min
CH:CHROMATOGRAPHY_SUMMARY        	for elution and 350 µL/min for re-equilibration.
CH:CHROMATOGRAPHY_TYPE           	Reversed phase
CH:INSTRUMENT_NAME               	Bruker Elute
CH:COLUMN_NAME                   	Hamilton Intensity Solo 2 C18(100 x 2.1 mm, 1.8 um)
CH:SOLVENT_A                     	Water (0.1% Formic Acid)
CH:SOLVENT_B                     	ACN (0.1% Formic Acid)
CH:FLOW_GRADIENT                 	The gradient program was: 0–2 min, 99% A: 1% B; 2–17 min, 99–1% A: 1–99%
CH:FLOW_GRADIENT                 	B; 17–20 min, 99% B: 1% A. The flow rate was fixed at 0.25 mL/min.
CH:FLOW_GRADIENT                 	Subsequently, 20–20.1 min 99% B to 99% A; 20.1–28.5 min, 99% A: 1% B at 0.35
CH:FLOW_GRADIENT                 	mL/min flow rate; 28.5–30 min; 99% A: 1% B at 0.25 mL/min.
CH:FLOW_RATE                     	250 uL/min
CH:COLUMN_TEMPERATURE            	35
#ANALYSIS
AN:ANALYSIS_TYPE                 	MS
#MS
MS:INSTRUMENT_NAME               	Bruker timsTOF
MS:INSTRUMENT_TYPE               	QTOF
MS:MS_TYPE                       	ESI
MS:ION_MODE                      	POSITIVE
MS:MS_COMMENTS                   	The MS analysis was performed using a TimsTOF (Bruker, Darmstadt, Germany) with
MS:MS_COMMENTS                   	Apollo II electrospray ionization (ESI) source. The drying gas was set to flow
MS:MS_COMMENTS                   	at 10 L/min and the drying temperature to 220C and the nebulizer pressure to 2.2
MS:MS_COMMENTS                   	bar. The capillary voltage was 4500 V and the end plate offset 500V. For
MS:MS_COMMENTS                   	metabolomics the scan range was 20-1300 m/z. The collision energy was set to 20
MS:MS_COMMENTS                   	eV, the cycle time to 0.5 seconds with a relative minimum intensity threshold of
MS:MS_COMMENTS                   	400 counts per thousand and target intensity of 20,000. Sodium formate was
MS:MS_COMMENTS                   	injected as an external calibrant in the first 0.3 minutes of each LC-MS/MS run.
MS:MS_COMMENTS                   	MetaboScape 4.0 software was used for metabolite processing and statistical
MS:MS_COMMENTS                   	analysis (Bruker Daltonics). The following parameters for molecular feature
MS:MS_COMMENTS                   	identification and "bucketing" were set in MS Comments the T-ReX 2D/3D workflow:
MS:MS_COMMENTS                   	For peak detection, a minimum intensity threshold of 1,000 counts is required,
MS:MS_COMMENTS                   	as well as a minimum peak duration of 7 spectra, with feature quantification
MS:MS_COMMENTS                   	determine using peak area. The file masses were recalibrated based on the
MS:MS_COMMENTS                   	external calibrant injected between 0-0.3 min.
#MS_METABOLITE_DATA
MS_METABOLITE_DATA:UNITS	AU
MS_METABOLITE_DATA_START
Samples	Amlodipine 01-01-10446	Amlodipine 01-02-10447	Amlodipine 02-01-10448	Amlodipine 02-02-10449	Amlodipine 03-01-10450	Amlodipine 03-02-10451	Amlodipine 04-01-10452	Amlodipine 04-02-10453	Amlodipine 05-01-10454	Amlodipine 05-02-10455	Amlodipine 06-01-10456	Amlodipine 06-02-10457	Control 01-01-10433	Control 01-02-10434	Control 02-01-10435	Control 02-02-10436	Control 03-01-10437	Control 03-02-10438	Control 04-01-10439	Control 04-02-10440	Control 05-01-10441	Control 05-02-10442	Control 06-01-10443	Control 06-02-10444
Factors	Treatment:Amlodipine	Treatment:Amlodipine	Treatment:Amlodipine	Treatment:Amlodipine	Treatment:Amlodipine	Treatment:Amlodipine	Treatment:Amlodipine	Treatment:Amlodipine	Treatment:Amlodipine	Treatment:Amlodipine	Treatment:Amlodipine	Treatment:Amlodipine	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control	Treatment:Control
1-Methyladenosine	1210	1106	940	1594	364	480	1152	1214	1328	884	674	532	976	966	584	704	534	844	654	1504	488	552	480	476
1-Methylguanine	1232	954	818	818	0	0	296	0	150	348	0	218	0	0	0	0	0	0	194	0	0	0	0	0
11a-Hydroxyprogesterone	15924	11976	15430	18026	18714	18114	18678	19898	20228	18504	20974	17822	12852	13154	15058	16660	17294	14378	15392	15714	20928	17648	15970	16860
2'-Deoxyguanosine 5'-monophosphate	1100	1196	814	1072	346	360	648	454	806	496	750	584	0	0	228	92	140	260	168	206	0	196	0	0
2,3-Butanediol	3120	2306	1600	2068	944	986	2210	2116	2418	2420	1934	2060	2234	2768	2680	2326	2166	2038	2398	2210	1918	1394	1608	2584
2-Ethyl-2-hydroxybutyric acid	116068	108332	79938	81946	47858	54148	85716	88632	90602	95750	79648	81744	108394	111316	104248	108628	81648	85292	89978	89394	71998	67552	81386	112130
2-Hydroxyadenine	6164	5502	4340	4624	4036	4150	6186	5330	3374	3230	2066	2610	2862	3390	3104	2620	2952	2580	3944	3880	1926	2062	2022	2832
2-Methyl-3-ketovaleric acid	9806	9528	7840	7886	12738	10110	10896	9716	8132	8484	2206	1776	10034	9698	9604	10168	8358	9288	8920	9152	8424	8112	11054	9732
2-Pyrrolidinone	750	374	262	504	522	414	446	544	144	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
3-Hexenedioic acid	478	540	418	502	390	620	386	458	378	460	396	384	190	196	548	326	246	204	280	368	302	344	378	364
3-Phenylbutyric acid	32594	33796	34758	32576	34854	36914	35544	33402	32652	33236	19664	18786	32648	32028	35484	34660	33672	31996	34034	31740	35056	34340	33254	33290
3a,6b,7b-Trihydroxy-5b-cholanoic acid	338	552	406	300	508	406	544	454	320	394	0	0	378	574	370	0	422	410	486	474	310	298	446	348
4-Guanidinobutanoic acid	306	362	0	332	264	436	440	244	342	366	0	184	478	276	630	342	532	216	332	1236	286	632	520	368
5'-Methylthioadenosine	20200	19476	20326	23902	8260	9820	19728	22918	18330	17324	17958	21810	8406	8106	10844	9864	11146	12030	17932	15722	12904	13204	15408	19502
5-Aminolevulinic acid	800	402	524	600	376	194	244	320	182	282	172	420	248	206	222	316	298	288	422	338	522	290	182	0
5-Hydroxy-L-tryptophan	1020	704	670	820	364	390	1046	770	560	526	540	568	502	374	764	502	644	698	744	876	536	452	660	846
5-Methoxytryptophol	0	876	520	612	0	498	898	866	598	264	300	234	794	912	1084	920	224	542	304	444	880	0	862	1484
5-Methylcytidine	0	816	0	0	1098	1182	994	0	586	704	692	280	400	980	580	304	198	432	0	172	434	394	0	0
6-(Methylamino) purine	688	1110	1082	696	564	542	896	856	576	364	392	314	238	380	0	156	0	0	360	254	0	0	0	0
7-Methylguanine	11240	9942	7884	8026	3928	3722	8552	8668	5912	5772	2510	2766	1736	1566	1172	1382	990	756	1628	1574	1218	1146	924	1444
8,11,14-Eicosatrienoic acid	704	714	596	500	654	620	660	606	878	744	704	584	1070	800	688	738	1000	710	1110	760	642	710	800	744
Acetoin	175744	213088	110706	117438	59796	69664	139448	147592	166980	135208	120588	0	2724	148384	135768	169458	159672	102026	183184	179652	83158	116314	142752	203790
Acetone	1104	1708	1218	1476	1370	1086	1548	1418	1638	932	1424	938	1092	1488	1578	1812	1940	1074	1216	940	2172	1216	1088	1004
Adenine	5914	4988	5870	5672	3142	2850	6478	6070	5214	4002	5570	5978	2304	2948	3288	2716	2818	3546	4402	4744	3460	4370	4866	5558
Adenosine	8690	7130	8794	8080	0	0	4616	1822	4962	7516	0	5346	8626	0	9776	9440	5922	6114	5940	6252	4456	242	100	6220
Aldosterone	610	738	618	478	728	692	540	782	260	0	0	0	710	846	844	1008	266	482	538	638	334	576	614	518
Androstenedione	1222	404	670	1264	554	1336	564	1364	1170	1218	1672	1240	1268	1318	1278	576	1098	624	484	934	560	186	1188	1500
Aspartyl-lysine	688	548	540	694	502	564	1044	0	718	554	0	0	452	678	664	0	452	0	644	592	564	538	580	536
Asymmetric dimethylarginine	1472	1538	1770	1876	1162	1162	1384	1208	1278	1090	986	1342	1442	1314	1062	1116	2000	1634	1814	1504	1142	1714	1608	1826
Azelaic acid	770	712	0	604	590	546	772	690	274	372	0	0	1188	752	1174	1090	388	700	0	594	508	0	826	854
Benzoic acid	2176	2292	2344	1846	0	0	1074	0	0	1456	0	236	0	188	1574	1348	1870	1818	1926	1914	2206	216	0	2038
Citramalic acid	742	658	908	754	430	268	562	1140	534	392	484	0	0	0	0	0	0	0	0	0	0	0	0	0
Cytosine	1230	1368	0	410	454	0	382	386	402	448	0	790	450	0	446	504	282	442	546	280	252	0	0	260
D-Alpha-aminobutyric acid	1660	1996	1744	1846	1420	1636	1408	1946	1550	1614	1642	1824	1492	1598	1574	1456	1460	1688	1450	1660	1286	1332	1710	1888
D-Arginine	1142	930	1058	1210	1154	802	1050	1094	904	1032	780	1226	810	810	766	920	632	764	1200	986	880	852	1526	1246
D-Lysine	724	552	644	672	554	602	586	634	634	682	564	406	290	0	532	654	944	550	758	788	892	882	734	870
D-Serine	1100	1036	4106	920	566	522	666	752	130	240	0	158	728	738	882	506	652	624	966	832	466	510	1004	3162
Deoxyinosine	588	0	388	648	0	272	350	362	312	286	0	248	572	350	454	544	458	452	562	420	570	396	670	610
DGTP	882	794	908	0	1022	1160	1100	858	910	846	0	0	0	874	832	976	806	892	802	850	732	714	1116	944
Diacetyl	13596	13780	12214	13002	15078	13428	15314	14030	12188	14716	5770	5378	14692	13536	12436	12854	12070	12728	14380	13468	13146	12158	14382	13564
DL-2-aminooctanoic acid	762	824	776	620	658	586	590	772	566	800	552	764	318	196	270	512	346	388	630	610	474	450	664	782
DL-Homocystine	566	878	548	802	552	0	586	598	372	574	0	0	904	858	822	738	650	380	696	638	652	314	824	542
Elaidic acid	1294	1476	1190	1006	2154	1446	1548	1244	0	1238	392	254	934	996	876	808	1264	978	1062	1178	798	586	1028	996
Ethanolamine	772	552	570	246	660	572	0	582	250	364	294	0	978	862	352	0	256	522	762	320	440	356	728	650
Gamma-Caprolactone	532	1796	456	438	0	252	390	358	704	310	424	374	400	0	498	346	446	350	188	460	298	344	550	450
Gamma-Glutamylcysteine	436	370	356	420	312	254	504	330	322	398	240	134	0	242	332	296	870	0	554	602	486	418	0	446
Glucosamine	8196	7862	5604	6414	2898	3364	7422	6490	4382	3882	1926	1652	1078	1158	926	964	670	768	962	1570	692	632	858	828
Glutathione	0	0	264	0	0	0	190	194	308	226	724	0	0	0	0	0	0	0	556	622	926	794	556	412
Glycerophosphocholine	1144	1754	1386	1534	1232	1126	1156	1518	992	964	776	1044	1084	1448	1138	2118	1400	1620	1488	2314	1392	1554	2220	2410
Glycine	276	268	154	476	0	0	324	208	0	214	558	476	224	352	348	0	228	356	666	732	2066	2076	616	796
Glycylproline	656	0	562	414	158	386	452	240	420	522	484	402	634	600	472	542	758	726	826	508	816	1066	1036	778
Guanosine	52752	51954	45794	50130	12486	1820	45878	38170	37618	36854	11848	26276	26722	6338	28088	29528	29920	30580	33038	34586	27338	13812	13204	37004
Hippuric acid	412	580	462	514	366	540	0	558	0	480	452	572	318	270	180	248	326	494	336	500	624	540	526	574
Hydrocinnamic acid	428	0	286	532	488	392	620	600	572	574	0	0	400	330	302	390	436	304	376	520	228	366	308	420
Hydroxyisocaproic acid	1056	936	484	952	946	0	978	948	936	1300	1180	1076	1032	950	1026	0	808	1158	1130	908	0	0	1234	1022
Hydroxyoctanoic acid	1680	0	1166	1160	902	1206	1558	1260	1354	1674	1358	1656	1378	1936	1540	1612	1352	1508	1698	1466	1094	1366	1264	1684
Hypoxanthine	87432	86024	85272	87738	26248	1334	69940	57122	66070	68216	31962	61298	41784	20554	45824	50418	65474	64154	72344	75822	65558	37928	37674	83976
Indole	5306	4520	4948	6930	3460	3080	4988	5182	4596	3188	3024	4022	2486	2600	2196	2694	3910	3976	3576	4066	4052	3532	4070	5752
Indoleacetic acid	220	0	0	0	420	238	232	222	136	0	0	0	0	0	306	0	620	502	468	338	608	442	566	740
Indoleacrylic acid	31992	32044	37122	40556	22796	22302	40020	37040	28774	29208	28504	27218	14214	14438	18370	16580	23854	24814	28638	24444	24570	23208	23036	34352
Inosine	25220	20470	22470	27506	7598	1944	18206	16742	17270	18250	9714	16632	9436	5938	13010	13050	17626	17356	21820	22282	19402	10314	10462	25054
Isovalerylcarnitine	17814	16956	18378	18064	9152	9190	13084	16394	16614	15158	17566	17530	5746	5026	8240	7602	9334	8830	12904	12844	14812	17294	13022	15640
L-Acetylcarnitine	4926	4340	5188	5904	2752	3046	4930	4640	3938	4304	5132	4130	2376	2146	2554	2766	3118	3862	2954	2910	2766	2534	2970	3470
L-Alpha-aminobutyric acid	1586	1156	1088	1620	946	1008	1146	1302	0	1072	900	752	1558	1188	1426	1606	1162	1070	1098	4476	1162	1064	1300	1406
L-Aspartic acid	372	496	506	428	426	670	366	452	438	520	222	414	386	544	514	412	382	380	672	424	380	428	338	402
L-Aspartyl-L-phenylalanine	0	0	2954	928	442	412	0	3184	412	0	0	0	678	642	498	528	728	904	750	974	658	578	894	1172
L-Carnitine	2286	2484	2614	2746	1746	2170	2176	2154	2158	2046	2116	1586	1696	1188	1166	1412	1600	1628	1884	1810	1940	1764	1642	1888
L-Cystine	374	478	420	258	514	520	514	654	456	486	184	0	256	228	560	380	378	450	406	462	466	374	598	370
L-Dopa	550	426	572	532	422	220	440	540	382	464	444	456	546	562	410	518	482	614	370	390	532	528	670	454
L-Glutamic acid	1630	1488	1548	1206	686	784	1132	1366	2406	1762	1418	1786	2794	2610	2916	3946	3268	3008	2318	2176	4204	3000	1820	2926
L-Glutamine	1242	1178	1416	1328	640	830	760	1086	1368	1396	940	714	1366	1130	1344	1668	1440	1546	1322	1414	0	942	1146	1230
L-Leucine	4734	4992	4840	5624	290	0	2084	1308	2596	3120	1096	3632	1564	242	1966	2618	2762	3120	3230	2914	2600	1098	0	3286
L-Malic acid	7452	7908	5898	5902	1682	168	5614	4044	4434	4120	2028	3262	2950	1666	3174	3282	3356	3448	4588	3776	3362	1666	1690	5024
L-Methionine	1424	1450	1370	1274	812	1200	1480	1876	950	998	1842	792	514	986	690	990	886	1024	1094	1128	1188	1192	1036	1062
L-Norleucine	828	788	936	1294	246	510	722	1000	560	628	540	780	324	434	292	442	406	558	730	362	272	372	652	482
L-Phenylalanine	9346	9220	10818	9896	3640	4254	9094	8770	8136	7672	8054	9056	5968	4644	5574	6388	7916	7280	7366	7432	6574	5348	6200	9890
L-Proline	19254	18990	18642	17050	22964	22626	23464	22474	16030	17758	1752	1552	376	488	210	314	270	264	474	140	384	592	424	372
L-Tryptophan	5946	4468	5906	6230	4140	3724	7222	6006	4174	4304	5544	4610	2740	3056	2804	2968	3826	3648	4152	4434	4526	3646	3620	5906
Leucinic acid	562	542	610	512	656	698	476	968	532	528	342	750	572	690	640	686	646	590	632	474	504	506	514	458
m-Coumaric acid	3770	3534	4524	3750	0	0	1714	1302	1860	1804	0	2276	1336	0	3024	3324	3468	3852	4256	4100	3370	0	0	3458
Medroxyprogesterone	512	508	546	406	636	690	532	0	0	452	654	726	318	518	576	526	494	482	466	434	592	436	564	498
Methylmalonic acid	2446	0	3512	222	2472	3440	2072	3846	1800	0	2558	1954	0	2670	0	0	2010	1888	2578	1512	0	2130	0	0
Methylsuccinic acid	0	522	700	606	536	394	492	896	720	300	430	304	468	0	522	442	708	754	758	1158	650	622	690	708
Mevalonic acid	998	852	1004	1086	576	612	752	856	1180	898	1578	1628	774	1244	1052	1230	1276	1278	1314	1232	984	1652	1092	876
N,N-Dimethylformamide	392	520	328	334	478	944	546	0	292	208	1394	226	0	1364	516	516	514	578	506	520	448	734	194	360
N-Acetyl-D-glucosamine	748	704	766	1066	784	680	812	916	1182	800	884	684	164	0	0	0	844	872	1424	1018	1048	1014	1042	1142
N-Acetyl-L-alanine	3818	4280	3914	4102	2906	3226	3718	3698	4506	4314	2732	3264	4114	2940	3878	44552	3058	3772	3354	3750	3152	4068	3068	3352
N-Methyl-a-aminoisobutyric acid	596	434	550	810	300	272	528	522	588	528	536	468	380	346	304	334	320	372	524	644	344	468	582	482
N-Methyl-D-aspartic acid	728	598	818	690	516	752	676	800	474	622	208	386	410	428	324	506	432	536	534	588	688	560	728	934
N-Methylnicotinamide	566	640	778	720	560	1056	716	710	684	466	592	594	332	332	514	270	484	478	496	522	492	776	494	564
Niacinamide	7032	8368	6952	7282	5934	5980	5946	6718	6088	5742	7360	4704	2476	3760	2812	3734	4246	5740	4778	5284	5080	4674	3410	5138
Nutriacholic acid	13262	10372	16282	16664	11968	12146	11074	8766	8634	7918	2466	4338	26712	11936	10340	7552	9474	9058	8546	16848	14184	9386	11306	8632
o-Tyrosine	6364	6396	6762	6162	0	0	2278	1584	1400	3484	276	248	1672	0	3552	3728	5710	5390	4936	5088	3976	0	0	5940
Oleic acid	0	260	432	0	716	0	750	498	644	438	0	488	0	532	530	436	560	634	566	392	650	0	400	0
PC(16:0/16:0)	612	742	754	786	0	730	506	574	762	898	1412	0	706	568	0	670	682	668	512	742	0	0	504	586
PC(18:1(9Z)/18:1(9Z))	24202	20620	23502	24362	16604	17198	14668	15848	19444	17514	0	64034	21914	20180	21928	21712	24466	23280	20648	23474	23214	26496	19298	21796
Perillic acid	2722	3576	2938	2680	2800	3454	2332	3278	2342	3240	1358	1446	2470	2664	3054	2488	3096	2744	5018	2848	2980	2166	3110	2786
Phenylacetaldehyde	18448	20140	20356	19824	19802	20000	17724	22234	19310	18970	4268	8992	19132	19316	19872	21288	19766	20138	19974	19636	20034	22122	19634	20998
Phenylacetic acid	1290	1368	1242	1488	0	0	998	884	1270	1294	446	1022	0	4508	694	0	704	0	1180	1074	1220	550	0	1196
Phenylpropiolic acid	1170	1234	1438	1356	0	0	784	0	0	0	0	1320	0	0	0	990	1206	1304	1512	1210	920	0	0	1392
Pregnenolone	5722	4076	3384	4090	5516	4630	5066	4838	4840	4546	2398	3040	4642	4412	5024	4320	5290	5080	5222	5396	5106	4732	5390	4370
Propionic acid	350	480	162	418	534	326	226	264	530	376	270	418	590	534	642	408	622	516	442	378	250	354	252	436
Pyridine	5850	4474	4404	5920	3248	4134	3370	4126	3854	3248	7066	3112	1314	2356	2420	2794	3152	3116	3534	3002	2804	2910	2744	2910
Pyroglutamic acid	574	1024	766	474	282	356	428	552	734	658	2444	2442	420	582	386	438	714	624	1814	1768	8070	9152	2386	3388
Pyrrolidonecarboxylic acid	760	632	504	510	204	420	374	410	668	500	344	438	656	494	650	496	890	930	1048	746	540	524	684	738
Pyruvaldehyde	2592	2756	3506	2932	2886	2724	2268	3032	2792	2904	1634	1692	2748	3406	2992	3764	3132	2732	3966	2666	2874	3526	3448	2460
Quinaldic acid	662	522	756	638	0	0	292	252	218	780	0	888	438	0	332	524	752	890	846	646	482	256	0	722
Saccharopine	1148	1338	772	770	342	564	588	792	764	512	176	732	1068	1056	1332	966	642	494	610	824	868	902	900	1176
Sebacic acid	11186	10418	6328	11534	2362	5640	8664	0	10888	11118	8582	7310	11214	10538	10904	9572	7110	7118	7798	9614	6192	5774	7088	11170
Spermine	10592	10780	12086	12218	4106	7162	12388	11378	15342	8662	8790	4622	9116	11608	8270	8958	11614	11604	12640	11030	6922	7714	17748	10048
Sphinganine	1856	2174	1728	2078	2092	1680	1560	1160	0	0	352	0	2864	2058	2112	1894	0	0	0	2228	1072	0	2442	0
Sphingosine	724	504	468	0	0	730	770	448	366	342	252	0	0	0	370	390	454	432	336	324	428	384	674	0
Stearic acid	848	712	706	776	642	956	840	1036	1050	890	1308	548	668	856	656	0	680	0	910	846	852	900	766	650
Succinylacetone	328	248	360	238	442	558	396	596	528	418	0	0	500	420	536	448	470	512	586	404	294	342	280	466
Taurodeoxycholic acid	2210	1920	1962	2012	2110	2300	2068	2186	2060	1924	0	1240	2868	2600	2310	2538	2420	2578	2362	2232	2508	0	2512	2016
Terephthalic acid	1170	962	1188	1126	1826	1826	1952	1428	576	536	0	0	1568	1044	1010	0	872	0	0	882	620	556	1188	860
Testosterone	462	310	322	466	560	346	420	510	540	364	176	0	300	410	410	382	398	480	308	248	252	382	382	540
Thymine	1438	1142	912	868	570	322	758	782	624	774	324	326	342	302	206	308	290	424	368	498	456	184	234	0
Tiglylglycine	1292	1080	1068	874	632	572	880	1056	756	730	860	878	1028	1122	1148	1408	934	730	1370	882	776	738	1098	1296
Traumatic acid	0	174	122	248	216	180	0	0	0	0	286	344	436	616	512	530	482	302	534	350	444	338	674	354
Trimethylamine	780	1024	1160	1176	1072	878	1114	1016	906	662	680	752	734	712	772	1008	704	816	742	826	738	948	820	724
Tryptophanol	664	606	1576	1566	372	322	454	398	1248	2062	1182	1174	1386	1104	910	1452	798	1054	1472	1258	1498	2182	1134	1790
Uracil	4552	5084	5430	3864	0	0	2330	602	2140	1594	0	3620	1410	0	2084	3484	2954	2488	3026	3424	2840	0	0	3670
Urea	354	366	376	552	542	318	334	402	312	130	306	322	600	478	938	468	536	700	528	538	768	546	442	304
Uridine	2352	2604	2420	2140	2410	2320	2426	2424	2046	2378	980	942	3290	3122	2756	2786	1792	2620	2238	2502	3422	3670	2756	3276
Xanthine	2250	2494	3884	3938	2714	1812	5008	4494	2194	2514	2580	2220	2128	2158	3310	2960	5226	5774	6548	6808	4600	3642	4140	5554
Xanthosine	1264	1166	2066	2132	1486	1140	2368	2304	1392	1326	980	1046	1340	974	1714	1328	2738	2694	3508	3298	2028	1986	2246	2944
MS_METABOLITE_DATA_END
#METABOLITES
METABOLITES_START
metabolite_name	RT [min]	m/z meas.	M meas.
1-Methyladenosine	5.15	282.1197	281.11243
1-Methylguanine	3.41	166.07243	165.06516
11a-Hydroxyprogesterone	0.31	331.22496	330.21768
2'-Deoxyguanosine 5'-monophosphate	5.02	348.0705	347.06322
2,3-Butanediol	8.06	91.07548	90.06821
2-Ethyl-2-hydroxybutyric acid	8.01	133.08602	132.07875
2-Hydroxyadenine	1.84	152.05674	151.04946
2-Methyl-3-ketovaleric acid	14.39	131.07043	130.06316
2-Pyrrolidinone	12.29	86.06075	85.05348
3-Hexenedioic acid	1.79	145.04956	144.04228
3-Phenylbutyric acid	15.44	165.091	164.08373
3a,6b,7b-Trihydroxy-5b-cholanoic acid	14.93	409.29527	408.28799
4-Guanidinobutanoic acid	13.3	146.09324	145.08596
5'-Methylthioadenosine	5.81	298.09701	297.08974
5-Aminolevulinic acid	4.36	132.06586	131.05858
5-Hydroxy-L-tryptophan	5.33	221.09235	220.08508
5-Methoxytryptophol	9.56	192.10259	191.09531
5-Methylcytidine	2.07	258.10914	257.10186
6-(Methylamino) purine	1.59	150.07757	149.07029
7-Methylguanine	5.12	166.07244	165.06517
8,11,14-Eicosatrienoic acid	0.87	307.26084	306.25356
Acetoin	8.09	89.05985	88.05258
Acetone	0.31	59.04924	58.04196
Adenine	5.81	136.06178	135.05451
Adenosine	4.56	268.10419	267.09691
Aldosterone	12.28	361.19886	360.19159
Androstenedione	0.31	287.19795	286.19067
Aspartyl-lysine	12.35	262.13766	261.13038
Asymmetric dimethylarginine	1.31	203.15038	202.1431
Azelaic acid	12.75	189.11239	188.10511
Benzoic acid	3	123.04404	122.03676
Citramalic acid	5.15	149.04561	148.03834
Cytosine	4.53	112.05063	111.04335
D-Alpha-aminobutyric acid	1.07	104.0705	103.06322
D-Arginine	1.16	175.11905	174.11177
D-Lysine	1.95	147.11292	146.10564
D-Serine	6.14	106.04983	105.04255
Deoxyinosine	4.9	253.09321	252.08593
DGTP	14.31	508.0064	506.99912
Diacetyl	15.4	87.04429	86.03702
DL-2-aminooctanoic acid	1.6	160.13338	159.12611
DL-Homocystine	13.52	269.06121	268.05393
Elaidic acid	17.72	283.26388	282.25661
Ethanolamine	10.72	62.06032	61.05304
Gamma-Caprolactone	8.47	115.07554	114.06826
Gamma-Glutamylcysteine	2.26	251.06953	250.06225
Glucosamine	5.49	180.08821	179.08093
Glutathione	4.97	308.09085	307.08357
Glycerophosphocholine	1.26	258.11013	257.10285
Glycine	4.94	76.03941	75.03213
Glycylproline	5.22	173.09227	172.085
Guanosine	4.74	284.09908	283.0918
Hippuric acid	6.98	180.06577	179.0585
Hydrocinnamic acid	10.7	151.0756	150.06832
Hydroxyisocaproic acid	5.4	133.0857	132.07843
Hydroxyoctanoic acid	8.23	161.11744	160.11016
Hypoxanthine	4.73	137.04581	136.0385
Indole	5.96	118.06502	117.05774
Indoleacetic acid	10.13	176.07076	175.06348
Indoleacrylic acid	5.97	188.07076	187.06348
Inosine	4.73	269.08819	268.08087
Isovalerylcarnitine	6.35	246.17032	245.16304
L-Acetylcarnitine	1.81	204.12313	203.11585
L-Alpha-aminobutyric acid	14.24	104.07073	103.06346
L-Aspartic acid	1.36	134.04479	133.03752
L-Aspartyl-L-phenylalanine	5.95	281.11279	280.10552
L-Carnitine	1.25	162.11258	161.10531
L-Cystine	1.28	241.03114	240.02386
L-Dopa	5.26	198.07491	197.06763
L-Glutamic acid	4.95	148.06049	147.05321
L-Glutamine	6.3	147.07673	146.06945
L-Leucine	3.03	132.10195	131.09467
L-Malic acid	4.72	135.0298	134.02252
L-Methionine	2.07	150.05778	149.0505
L-Norleucine	6.06	132.10198	131.09471
L-Phenylalanine	5.07	166.0864	165.07912
L-Proline	14.14	116.07089	115.06361
L-Tryptophan	5.96	205.09734	204.09006
Leucinic acid	0.49	133.08591	132.07863
m-Coumaric acid	3	165.05475	164.04748
Medroxyprogesterone	5.67	345.24019	344.23291
Methylmalonic acid	2.06	119.03504	118.02777
Methylsuccinic acid	5	133.04954	132.04227
Mevalonic acid	2.12	149.08092	148.07365
N,N-Dimethylformamide	2.13	74.06016	73.05289
N-Acetyl-D-glucosamine	1.33	222.09737	221.09009
N-Acetyl-L-alanine	1.37	132.06546	131.05819
N-Methyl-a-aminoisobutyric acid	1.6	118.0862	117.07893
N-Methyl-D-aspartic acid	1.66	148.06044	147.05316
N-Methylnicotinamide	1.24	137.07092	136.06364
Niacinamide	2.1	123.05523	122.04795
Nutriacholic acid	19.71	413.26653	390.27735
o-Tyrosine	3.01	182.0813	181.07403
Oleic acid	0.45	283.2634	282.25613
PC(16:0/16:0)	20.3	734.56959	733.56231
PC(18:1(9Z)/18:1(9Z))	17.6	786.60186	785.59458
Perillic acid	15.37	167.10701	166.09974
Phenylacetaldehyde	15.44	121.06492	120.05764
Phenylacetic acid	4.74	137.06026	136.05298
Phenylpropiolic acid	3.03	147.04409	146.03682
Pregnenolone	15.4	317.24759	316.24031
Propionic acid	1.32	75.04438	74.0371
Pyridine	2.09	80.04965	79.04237
Pyroglutamic acid	5.03	130.04992	129.04265
Pyrrolidonecarboxylic acid	6.31	130.04996	129.04268
Pyruvaldehyde	15.49	73.02878	72.0215
Quinaldic acid	3.93	174.05498	173.0477
Saccharopine	1.5	277.13937	276.13209
Sebacic acid	7.94	102.06764	202.12073
Spermine	0.82	203.22315	202.21588
Sphinganine	12.33	302.30641	301.29913
Sphingosine	17.57	300.2903	299.28302
Stearic acid	14.96	285.27916	284.27188
Succinylacetone	17.9	159.06518	158.0579
Taurodeoxycholic acid	13.75	500.29936	499.29209
Terephthalic acid	19.72	149.02342	166.02675
Testosterone	12.29	289.21628	288.209
Thymine	4.94	127.05038	126.04311
Tiglylglycine	1.25	158.08125	157.07398
Traumatic acid	9.4	229.14368	228.13641
Trimethylamine	1.18	60.0809	59.07362
Tryptophanol	5.69	162.09145	161.08417
Uracil	3.05	113.03448	112.0272
Urea	15.56	61.03963	60.03235
Uridine	12.51	245.07873	244.07145
Xanthine	4.99	153.04077	152.03349
Xanthosine	5.01	285.08325	284.07597
METABOLITES_END
#END